Evidence map›Paper›PMID 41306593›Full record

ArticleFrontiers in cellular and infection microbiology2025

Clinical characteristics of

Hangdi Xu, Yueqing Xu, Jing Gu, Xiaoling Wang, Bo Liao, Pengpeng Zhou, Shengjun Wu, Ran Tao, Ying Fu

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Frontiers in medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hangdi Xu *Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Disease, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Yueqing Xu *Department of Pulmonary and Critical Care Medicine, the First Division Hospital of Xinjiang Production and Construction Corps, Akesu, China.
Jing GuGuangzhou University of Chinese Medicine, Guangzhou, China.
Xiaoling WangDepartment of Pulmonary and Critical Care Medicine, the First Division Hospital of Xinjiang Production and Construction Corps, Akesu, China.
Bo LiaoDepartment of Pulmonary and Critical Care Medicine, the First Division Hospital of Xinjiang Production and Construction Corps, Akesu, China.
Pengpeng ZhouDepartment of Pulmonary and Critical Care Medicine, the First Division Hospital of Xinjiang Production and Construction Corps, Akesu, China.
Shengjun WuDepartment of Clinical Laboratory, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Ran TaoDepartment of Pathology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ying FuDepartment of Clinical Laboratory, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: A retrospective analysis was conducted on patients confirmed with Results: Seven patients were diagnosed with Discussion:

Indexed as

High-Throughput Nucleotide SequencingLung AbscessTreponema denticolaTreponemal InfectionsAdultAgedAnti-Bacterial AgentsFemaleHumansMaleMetagenomicsMiddle AgedRetrospective StudiesAnti-Bacterial Agentscase seriesclinical characteristicslung abscessmetagenomic next-generation sequencingTreponema denticola

Identifiers

PMID41306593
PMCPMC12644101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.